Stocks / NASDAQ / HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

Our Opinion

HTG Molecular Diagnostics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“The HTG Edge system enables a seamless transition from early clinical research where biomarker discovery may have been done in cell or animal models to translational medicine and clinical development where the preferred sample type is formalin-fixed, paraffin embedded (FFPE) tissue.” Read the following article

Company Description

HTG Molecular Diagnostics, Inc. provides molecular technology solutions. It offers products for miRNA, and mRNA measurement for translational research/medicine and molecular diagnostics. Its qNPA molecular technology platform detects changes in gene expression levels; especially from formalin-fixed, paraffin embedded tissue and other biological sample types. It also offers pharma and diagnostics services. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ. [Source: MarketWatch]

Company Website: